Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-22-000741
Filing Date
2022-07-05
Accepted
2022-07-05 16:30:35
Documents
2
Group Members
ORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP VI LLCORBIMED ISRAEL GP II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 ss1139058_sc13da.htm SC 13D/A 118133
2 JOINT FILING AGREEMENT ss1139058_ex9901.htm EX-99.1 7929
  Complete submission text file 0000947871-22-000741.txt   127694
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Subject) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91200 | Film No.: 221065370
SIC: 2834 Pharmaceutical Preparations